US 11274123
1,2,4-oxadiazole compounds as inhibitors of CD47 signalling
granted A61KA61K38/00A61P
Quick answer
US patent 11274123 (1,2,4-oxadiazole compounds as inhibitors of CD47 signalling) held by Aurigene Discovery Technologies Limited expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61P, A61P25/28, A61P31/04